216 related articles for article (PubMed ID: 25146687)
1. The need to improve current psychopharmacotherapy before developing new drugs.
Ceskova E
Expert Opin Pharmacother; 2014 Oct; 15(14):1969-73. PubMed ID: 25146687
[TBL] [Abstract][Full Text] [Related]
2. Phenotyping and genotyping of drug metabolism to guide pharmacotherapy in psychiatry.
Hiemke C; Shams M
Curr Drug Deliv; 2013 Feb; 10(1):46-53. PubMed ID: 22998042
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic monitoring of psychotropic drugs and pharmacogenetic tests in psychiatry].
Voirol P; Eap CB; Baumann P
Rev Med Suisse Romande; 2000 Feb; 120(2):99-104. PubMed ID: 10748694
[No Abstract] [Full Text] [Related]
4. [Clinical significance of pharmacogenetics in psychiatry].
Skrętkowicz J; Barańska M; Rychlik-Sych M
Wiad Lek; 2013; 66(2 Pt 2):185-91. PubMed ID: 25775815
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 enzymes and psychiatric drugs. How a patient's genetic profile and other medications can alter drug response.
Harv Ment Health Lett; 2009 Feb; 25(8):4-5. PubMed ID: 19241615
[No Abstract] [Full Text] [Related]
6. Pharmacogenomics Can Enhance Prescribing of Psychiatric Medications.
Narang P; Johnson A; Enja M; Lippmann S
South Med J; 2016 Oct; 109(10):628-630. PubMed ID: 27706500
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic drug monitoring and pharmacogenetics--is this a way towards creative psychopharmacotherapy?
Plesničar BK; Plesničar A
Psychiatr Danub; 2014 Jun; 26(2):96-9. PubMed ID: 24909244
[TBL] [Abstract][Full Text] [Related]
8. Tools for optimizing pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants.
de Leon J
Pharmacogenomics; 2021 Aug; 22(13):805-808. PubMed ID: 34344160
[No Abstract] [Full Text] [Related]
9. Influencing CYP enzymes to boost psychiatric treatment: a review on clinical evidence.
van Hasselt FM; Coehorst Y; Wilffert B; Loonen AJ
Pharmacopsychiatry; 2013 Mar; 46(2):43-6. PubMed ID: 23037948
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic drug monitoring of psychoactive drugs during pregnancy in the genomic era: challenges and opportunities.
DeVane CL; Stowe ZN; Donovan JL; Newport DJ; Pennell PB; Ritchie JC; Owens MJ; Wang JS
J Psychopharmacol; 2006 Jul; 20(4 Suppl):54-9. PubMed ID: 16785271
[TBL] [Abstract][Full Text] [Related]
11. Personalized prescribing: a new medical model for clinical implementation of psychotropic drugs.
Eap CB
Dialogues Clin Neurosci; 2016 Sep; 18(3):313-322. PubMed ID: 27757065
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomics in psychiatry: from therapeutic drug monitoring to genomic medicine.
Crettol S; de Leon J; Hiemke C; Eap CB
Clin Pharmacol Ther; 2014 Mar; 95(3):254-7. PubMed ID: 24196844
[No Abstract] [Full Text] [Related]
13. Clinical applications of CYP genotyping in psychiatry.
Spina E; de Leon J
J Neural Transm (Vienna); 2015 Jan; 122(1):5-28. PubMed ID: 25200585
[TBL] [Abstract][Full Text] [Related]
14. Managing Psychotropic Medications in Complex, Real-World Patients Using Comprehensive Therapeutic Drug Monitoring.
Sutherland JJ; Morrison RD; Daniels JS; Milne SB; Ryan TP
ACS Chem Neurosci; 2017 Aug; 8(8):1641-1644. PubMed ID: 28640591
[TBL] [Abstract][Full Text] [Related]
15. Have we successfully implemented CYP2D6 genotyping in psychiatry?
de Leon J
Expert Opin Drug Metab Toxicol; 2017 Dec; 13(12):1201-1203. PubMed ID: 29164956
[No Abstract] [Full Text] [Related]
16. Personalized medicine in psychiatry: new technologies and approaches.
Costa e Silva JA
Metabolism; 2013 Jan; 62 Suppl 1():S40-4. PubMed ID: 23018148
[TBL] [Abstract][Full Text] [Related]
17. Drug-Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications.
Smolders EJ; de Kanter CT; de Knegt RJ; van der Valk M; Drenth JP; Burger DM
Clin Pharmacokinet; 2016 Dec; 55(12):1471-1494. PubMed ID: 27317413
[TBL] [Abstract][Full Text] [Related]
18. Where are we today with personalized medicine?
Howland RH
J Psychosoc Nurs Ment Health Serv; 2012 Nov; 50(11):11-3. PubMed ID: 23066831
[TBL] [Abstract][Full Text] [Related]
19. Introduction. Pharmacokinetics of psychotropic agents: why and how they are relevant to treatment.
Preskorn SH
J Clin Psychiatry; 1993 Sep; 54 Suppl():3-7; discussion 55-6. PubMed ID: 8407857
[No Abstract] [Full Text] [Related]
20. [Special characteristics of psychopharmacotherapy of elderly patients].
Bauer J
Fortschr Med; 1996 Sep; 114(25):297-302. PubMed ID: 8974977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
